Join the team

Check out the open positions below to join us in our mission to provide better MRD testing for better cancer treatment decisions.

HS-grid-items (3)
HS-grid-items (1)

Agile. Flexible. Passionate.

Mission and culture

Haystack Oncology is a company employing next-generation ctDNA detection technology to deliver industry-leading minimal residual disease (MRD) testing for personalized cancer treatment. Our mission is to improve the human condition through innovative diagnostics, and our culture is defined by the professionals who have built this company: hard-working, roll-up-your-sleeves people who embrace growth and are innovative, self-starting, and collaborative. That is the sort of people who have built this company and it is who will lead it into the future. 


Job openings

At Haystack Oncology, your contributions will provide tangible, measurable benefits to patients. Haystack offers competitive pay, generous benefits, remote work options, and endless career opportunities limited only by your imagination. Join us at Haystack and turn your passion into a fulfilling, rewarding career. 

Wissenschaftler*in Assay-Entwicklung / Scientist Assay Development

Haystack Oncology Hamburg, Hamburg, Germany On-site
Full-time · Biotechnology Research

Quality Assurance (QA) Analyst

Full-time · Quality Assurance

Haystack Oncology is a precision medicine company based on over two decades of technology and clinical development in the field of liquid biopsy.

Bioinformatics Scientist

Full-time · Bioinformatics

The Bioinformatics Scientist will be proficient in data-driven, computational analysis necessary to develop, launch, and innovate in all aspects of oncology molecular test product development.

Laboratory Automation Engineer

Full-time · Technical Operations

The Laboratory Automation Engineer is responsible for developing, implementing, and scaling automated workflows within a regulated next-generation sequencing molecular diagnostics lab.

Sr. Manager of Reimbursement

Full-time · Commercial Operations

Haystack Oncology is launching an innovative blood-based molecular diagnostic test to improve cancer detection, characterization and treatment.